Is it possible to obtain an SPC on the basis of an MA granted for a new formulation of an active ingredient that has already been authorized ?
In the Neurim case (C-130/11 ; 19 July 2012), the Advocate General of the Court of Justice of the European Union (CJEU), recognized the possibility of obtaining an SPC for a new […]